Clinical Trials Logo

Hearing Loss clinical trials

View clinical trials related to Hearing Loss.

Filter by:

NCT ID: NCT03866460 Active, not recruiting - Hearing Loss Clinical Trials

Determining Whether Intra-Arterial Carboplatin Causes Hearing Loss in Children

Start date: March 6, 2019
Phase:
Study type: Observational

The purpose of this study is to find out how often hearing loss occurs in patients with retinoblastoma after receiving treatment with intra-arterial carboplatin.

NCT ID: NCT03742089 Active, not recruiting - Clinical trials for Hearing Loss, Conductive

Evaluation of the BHX Implant in Children With a BAHS

Start date: May 22, 2018
Phase:
Study type: Observational

The purpose of this study is to in a proactive manner collect high quality data from pediatric patients who have undergone a bone anchored hearing surgery, using the Ponto BHX implant, in clinical practice. This to further increase the knowledge of bone anchored hearing systems in the pediatric population.

NCT ID: NCT03685461 Active, not recruiting - Hearing Loss Clinical Trials

AB-Intra- and Post-Operative Measures of Auditory Function

AB-ECOG
Start date: October 1, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to see how the inner ear responds to sound delivered to the ear canal during and after your cochlear implant surgery. This information may be helpful in telling us how well a cochlear implant performs after surgery.

NCT ID: NCT03669536 Active, not recruiting - Obesity Clinical Trials

Determinants of Cognitive Impairment Among Geriatrics

Start date: August 1, 2017
Phase:
Study type: Observational

This study aims to explore the determinants of cognitive impairment among Indonesian geriatrics in an Old Age Home.

NCT ID: NCT03569228 Active, not recruiting - Hearing Loss Clinical Trials

Efficacy of a Coupler-based Fitting Approach for Experienced Users Receiving Replacement Hearing Aids

Start date: October 28, 2019
Phase: N/A
Study type: Interventional

Hearing loss is among the top service-connected disabilities in Veterans. Hearing aids are the primary intervention for hearing loss. Half of the hearing aids dispensed in the VA are to Veterans who are receiving replacement amplification. Many Veterans would like their replacement hearing aids mailed to them, but they are required to travel to the clinic so that the fit of the hearing aid can be verified. There are standard fitting procedures, such as those used in infants and children, that use a coupler to simulate the patient's real ear to verify the hearing aid fitting. The results of this study should determine the efficacy of a coupler-based hearing-aid fitting protocol that would not require the Veteran to attend the fitting appointment, thereby contributing to improved Veteran-Centric care.

NCT ID: NCT03557879 Active, not recruiting - Hearing Impairment Clinical Trials

Exome Analysis in Hearing Impaired Patients

NGS-NSHL
Start date: June 4, 2018
Phase:
Study type: Observational

Hearing impairment is the most frequent sensory deficit in humans and affects one newborn out of 500. The prevalence rises to 3,5/1000 in teenagers due to retarded forms. Most of hearing impairments (about two thirds) have a genetic origin, with recessive, dominant or X-linked mode of inheritance. Some rare forms can be linked to mitochondrial DNA. Molecular diagnosis (i.e. defining the molecular basis of the disease, genes and precise DNA variants) is essential for the follow-up of patients and families. The project intends to perform exome sequencing on 30 samples of families presenting with hearing impairment. Families have been included based on the genetic origin of the hearing impairment (familial cases) and the exclusion of the involvement of 74 known deafness genes. Exome sequencing (sequencing of the coding regions of all known genes, about 22,000) in these cases may underly new gene/disease relationships.

NCT ID: NCT03548779 Active, not recruiting - Clinical trials for Autism Spectrum Disorder

North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2

NCGENES2
Start date: September 28, 2018
Phase: N/A
Study type: Interventional

The "North Carolina Clinical Genomic Evaluation by Next-gen Exome Sequencing, 2 (NCGENES 2)" study is part of a larger consortium project investigating the clinical utility, or net benefit of an intervention on patient and family well-being as well as diagnostic efficacy, management planning, and medical outcomes. A clinical trial will be implemented to compare (1) first-line exome sequencing to usual care and (2) participant pre-visit preparation to no pre-visit preparation. The study will use a randomized controlled design, with 2x2 factorial design, coupled with patient-reported outcomes and comprehensive clinical data collection addressing key outcomes, to determine the net impact of diagnostic results and secondary findings.

NCT ID: NCT03379870 Active, not recruiting - Clinical trials for Hearing Disorders in Children

Outcomes in Children With Pre-operative Residual Hearing

Start date: May 25, 2018
Phase: N/A
Study type: Interventional

Purpose: Routine clinical care and pilot study data has shown evidence of postoperative hearing preservation in pediatric cochlear implant (CI) recipients. The primary aim of this study is to investigate speech perception performance in pediatric CI recipients with functional pre-operative hearing. Participants: Two cohorts of CI recipients aged 6 through 17 years who had pre-operative low frequency residual hearing. Subjects in Arm 1 will present with a post-operative low frequency pure tone average (125, 250, and 500 Hz) of ≤ 75 dB HL, and those in Arm 2 will present with a post-operative low frequency pure tone average (LFPTA) that exceeds 75 dB HL. Procedures (methods): Subjects will complete speech perception and quality of life testing during post-operative intervals. Subjects in Arm 1 will be evaluated with the hearing aid alone (HA-alone) and with combined electric-acoustic stimulation (EAS). Subjects in Arm 2 will be evaluated with the CI-alone.

NCT ID: NCT03352154 Active, not recruiting - Clinical trials for Hearing Loss, Sensorineural

Long Latency Auditory Evoked Potentials (P300) Outcomes in Patients With Unilateral Cochlear Implants

Start date: November 20, 2016
Phase: N/A
Study type: Interventional

Bilateral severe to profound hearing loss is a socially disabling handicap. Cochlear implants can be used to improve hearing in cases where conventional hearing aids are not effective. There are few studies about the long latency Auditory Evoked Potential (P300), in individuals with hearing loss and Cochlear Implant (CI) users. The aim of this project is to study the behavior of P300 in users of unilateral CI.

NCT ID: NCT03255161 Active, not recruiting - Hearing Loss Clinical Trials

Randomized Controlled Trial of a Community Health Worker Program on Hearing Loss (Oyendo Bien)

Start date: August 19, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to test the effectiveness of a community health worker intervention to expand access to hearing health care among older adults facing health disparities.